EUVIMEDEUVIMED entdecken
Crossref

Ensemble docking based virtual screening of SARS‐CoV‐2 main protease inhibitors

Anastasia D Fomina iD, Victoria I Uvarova, Liubov I Kozlovskaya, Vladimir A Palyulin, Dmitry I Osolodkin, Aydar A Ishmukhametov

Molecular Informatics · 2024

DOI: 10.1002/minf.202300279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Informatics, 2024. Verfasst von Anastasia D Fomina und 5 weiteren Autor:innen. Beteiligte Einrichtung: FSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), 108819, Moscow, Russia. Hauptthemen laut MEDLINE: SARS-CoV-2, Molecular Docking Simulation, Protease Inhibitors, Coronavirus 3C Proteases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 88 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

During the first years of COVID‐19 pandemic, X‐ray structures of the coronavirus drug targets were acquired at an unprecedented rate, giving hundreds of PDB depositions in less than a year. The main protease (Mpro) of severe acute respiratory syndrome‐related coronavirus 2 (SARS‐CoV‐2) is the primary validated target of direct‐acting antivirals. The selection of the optimal ensemble of structures of Mpro for the docking‐driven virtual screening campaign was thus non‐trivial and required a systematic and automated approach. Here we report a semi‐automated active site RMSD based procedure of ensemble selection from the SARS‐CoV‐2 Mpro crystallographic data and virtual screening of its inhibitors. The procedure was compared with other approaches to ensemble selection and validated with the help of hand‐picked and peer‐reviewed activity‐annotated libraries. Prospective virtual screening of non‐covalent Mpro inhibitors resulted in a new chemotype of thienopyrimidinone derivatives with experimentally confirmed enzyme inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Molecular Docking SimulationProtease InhibitorsCoronavirus 3C ProteasesAntiviral AgentsHumansCatalytic DomainCOVID-19Cysteine EndopeptidasesViral Nonstructural ProteinsPandemicsDrug Evaluation, Preclinical

Stichwörter der Autor:innen

SARS-CoV-2coronavirus main proteaseensemble dockingprotease inhibitorsvirtual screening

Substanzen

Protease InhibitorsCoronavirus 3C ProteasesAntiviral AgentsCysteine EndopeptidasesViral Nonstructural Proteins

Autor:innen und Institutionen

  • FSASI "Chumakov FSC R&D IBP RAS" (Institute of Poliomyelitis), 108819, Moscow, Russia.
  • Department of Chemistry, Lomonosov Moscow State University, 119991, Moscow, Russia.
  • Institute of Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, 119991, Moscow, Russia.

ORCID-Profile: Anastasia D Fomina

Zitieren

APA

Fomina, A. D., Uvarova, V. I., Kozlovskaya, L. I., Palyulin, V. A., Osolodkin, D. I., & Ishmukhametov, A. A. (2024). Ensemble docking based virtual screening of SARS‐CoV‐2 main protease inhibitors. Molecular Informatics. https://doi.org/10.1002/minf.202300279

Vancouver

Fomina AD, Uvarova VI, Kozlovskaya LI, Palyulin VA, Osolodkin DI, Ishmukhametov AA. Ensemble docking based virtual screening of SARS‐CoV‐2 main protease inhibitors. Molecular Informatics. 2024. doi:10.1002/minf.202300279

BibTeX
@article{Fomina2024,
  author = {Fomina, Anastasia D and Uvarova, Victoria I and Kozlovskaya, Liubov I and Palyulin, Vladimir A and Osolodkin, Dmitry I and Ishmukhametov, Aydar A},
  title = {Ensemble docking based virtual screening of SARS‐CoV‐2 main protease inhibitors},
  journal = {Molecular Informatics},
  year = {2024},
  doi = {10.1002/minf.202300279}
}
Kostenlos starten →